Prescription drug · ANDA
Sucralfate NDC 63629-9152
Sucralfate 1 g/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63629-9152-1 | 63629915201 | 100 TABLET in 1 BOTTLE, PLASTIC (63629-9152-1)Marketed from Jan 26, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sucralfate
- Generic name (nonproprietary)
- sucralfate
- Active ingredients
- Sucralfate — 1 g/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074415
- Marketing start
- Listing expires
- Other FDA classes
- Organometallic Compounds (Chemical structure)
- Identifiers
- Product ID 63629-9152_68eb54fd-5a5e-4803-a43e-1c3134416377SPL ID 68eb54fd-5a5e-4803-a43e-1c3134416377SPL set ID 7b05323d-4695-41d7-8236-1e7b4e8f2a1eRxCUI 314234UNII XX73205DH5
- Pharmacologic class
- Aluminum Complex
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463629915201followed by a unit qualifier and the quantityPackage 63629-9152-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074415
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-541 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0188 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Direct_Rx | 72189-429 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | A-S Medication Solutions | 50090-6455 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 72162-2264 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 63629-9153 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 71335-2114 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3478 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-881 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Chartwell RX, LLC | 62135-436 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Proficient Rx LP | 82804-102 |